Patents by Inventor Steven Wayne Pedersen

Steven Wayne Pedersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • -4-[[(5)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
    Patent number: 8299060
    Abstract: Abstract Compounds of a formula entitled, trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid, as a free acid or a pharmaceutically acceptable salt thereof, hydrate, and hydrate in crystalline form; pharmaceutical formulations; and methods of use are disclosed.
    Type: Grant
    Filed: June 28, 2010
    Date of Patent: October 30, 2012
    Assignee: Eli Lilly and Company
    Inventors: Xinchao Chen, Scott Alan Frank, Steven Wayne Pedersen, David Michael Remick
  • Trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
    Publication number: 20120058990
    Abstract: Abstract Compounds of a formula entitled, trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid, as a free acid or a pharmaceutically acceptable salt thereof, hydrate, and hydrate in crystalline form; pharmaceutical formulations; and methods of use are disclosed.
    Type: Application
    Filed: June 28, 2010
    Publication date: March 8, 2012
    Applicant: ELI LILLY AND COMPANY
    Inventors: Xinchao Chen, Scott Alan Frank, Steven Wayne Pedersen, David Michael Remick
  • Trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
    Publication number: 20100331309
    Abstract: Compounds of a formula entitled, trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid, as a free acid or a pharmaceutically acceptable salt thereof; and hydrates and other solvates in crystalline form; pharmaceutical formulations; and methods of use are disclosed.
    Type: Application
    Filed: June 28, 2010
    Publication date: December 30, 2010
    Applicant: ELI LILLY AND COMPANY
    Inventors: Xinchao Chen, Scott Alan Frank, David Michael Remick, Steven Wayne Pedersen
  • Prodrugs of excitatory amino acids
    Patent number: 7456221
    Abstract: This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further relates to methods of using, and pharmaceutical compositions comprising, the compounds for the treatment of neurological disorders and psychiatric disorders.
    Type: Grant
    Filed: July 5, 2007
    Date of Patent: November 25, 2008
    Assignee: Eli Lilly and Company
    Inventors: David Scott Coffey, James Allen Monn, Concepcion Pedregal-Tercero, Steven Wayne Pedersen
  • Crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
    Patent number: 7381826
    Abstract: The present invention provides novel crystalline forms of {2-[1-(3,5-bistrifluoromethylbenzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone, compositions thereof, intermediates thereof, methods of using the same, processes for making the same, and processes for making intermediates thereof.
    Type: Grant
    Filed: October 12, 2004
    Date of Patent: June 3, 2008
    Assignee: Eli Lilly and Company
    Inventors: Alfio Borghese, David Scott Coffey, Pamela Kaye Footman, Steven Wayne Pedersen, Susan Marie Reutzel-Edens, Shella Lenyonga Tameze, Carsten Timpe, Carsten Weber
  • Prodrugs of excitatory amino acids
    Patent number: 7256217
    Abstract: This invention relates to synthetic excitatory amino acid prodrugs according to formula (I) and processes for their preparation.
    Type: Grant
    Filed: December 14, 2001
    Date of Patent: August 14, 2007
    Assignee: Eli Lilly and Company
    Inventors: David Scott Coffey, James Allen Monn, Concepcion Pedregal-Tercero, Steven Wayne Pedersen
  • Process for preparing 4-substituted piperidines
    Publication number: 20030153764
    Abstract: The present invention provides a process for preparing N-protected-4-substituted piperidines of formula (I) wherein Pg represents a suitable nitrogen protecting group; X represents a heterocycle, substituted heterocycle, substituted alkenyl or substituted aryl wherein the substituted heterocycle, substituted alkenyl or substituted aryl are substituted with from 1 to 3 suitable activating groups; and R1, R2, R3, R4, R5, R6, R7, and R8 each independently represent an alkyl, alkenyl, cycloalkyl, aryl, substituted aryl, heterocycle, or substituted heterocycle, comprising treating a compound of formula (II) wherein the substituents are defined as above, with triethylsilane and trifluoroacetic acid.
    Type: Application
    Filed: May 28, 2002
    Publication date: August 14, 2003
    Inventors: Alexander Glenn Godfrey, Steven Wayne Pedersen